» Articles » PMID: 33668203

The Implications of NcRNAs in the Development of Human Diseases

Overview
Journal Noncoding RNA
Date 2021 Mar 6
PMID 33668203
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The mammalian genome comprehends a small minority of genes that encode for proteins (barely 2% of the total genome in humans) and an immense majority of genes that are transcribed into RNA but not encoded for proteins (ncRNAs). These non-coding genes are intimately related to the expression regulation of protein-coding genes. The ncRNAs subtypes differ in their size, so there are long non-coding genes (lncRNAs) and other smaller ones, like microRNAs (miRNAs) and piwi-interacting RNAs (piRNAs). Due to their important role in the maintenance of cellular functioning, any deregulation of the expression profiles of these ncRNAs can dissemble in the development of different types of diseases. Among them, we can highlight some of high incidence in the population, such as cancer, neurodegenerative, or cardiovascular disorders. In addition, thanks to the enormous advances in the field of medical genomics, these same ncRNAs are starting to be used as possible drugs, approved by the FDA, as an effective treatment for diseases.

Citing Articles

miRNAs and their multifaceted role in cutaneous wound healing.

Mansour R, Mageed S, Awad F, Sadek M, Adel S, Ashraf A Funct Integr Genomics. 2025; 25(1):33.

PMID: 39903291 DOI: 10.1007/s10142-025-01535-y.


Pivotal Role of miRNA-lncRNA Interactions in Human Diseases.

Pooresmaeil F, Azadi S, Hasannejad-Asl B, Takamoli S, Bolhassani A Mol Biotechnol. 2024; .

PMID: 39673006 DOI: 10.1007/s12033-024-01343-y.


Circular RNA circEZH2 Promotes Lung Adenocarcinoma Progression by Regulating microRNA-495-3p/Tumor Protein D52 Axis and Activating Nuclear Factor-Kappa B Pathway.

Chen L, Xiang T, Xing J, Lu X, Wei S, Wang H Int J Gen Med. 2024; 17:4419-4433.

PMID: 39359616 PMC: 11446202. DOI: 10.2147/IJGM.S473202.


ciRS-7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myeloma.

Papatsirou M, Kontos C, Ntanasis-Stathopoulos I, Malandrakis P, Theodorakakou F, Liacos C EJHaem. 2024; 5(4):677-689.

PMID: 39157602 PMC: 11327729. DOI: 10.1002/jha2.903.


Non-coding RNAs as therapeutic targets in cancer and its clinical application.

Leng X, Zhang M, Xu Y, Wang J, Ding N, Yu Y J Pharm Anal. 2024; 14(7):100947.

PMID: 39149142 PMC: 11325817. DOI: 10.1016/j.jpha.2024.02.001.


References
1.
Wang W, Wang Y, Hu Y, Lin Q, Chen R, Liu H . HDncRNA: a comprehensive database of non-coding RNAs associated with heart diseases. Database (Oxford). 2018; 2018. PMC: 6059085. DOI: 10.1093/database/bay067. View

2.
Li J, Xue Y, Amin M, Yang Y, Yang J, Zhang W . ncRNA-eQTL: a database to systematically evaluate the effects of SNPs on non-coding RNA expression across cancer types. Nucleic Acids Res. 2019; 48(D1):D956-D963. PMC: 6943077. DOI: 10.1093/nar/gkz711. View

3.
Eken S, Jin H, Chernogubova E, Li Y, Simon N, Sun C . MicroRNA-210 Enhances Fibrous Cap Stability in Advanced Atherosclerotic Lesions. Circ Res. 2016; 120(4):633-644. DOI: 10.1161/CIRCRESAHA.116.309318. View

4.
Muhammad A, Waheed R, Khan N, Jiang H, Song X . piRDisease v1.0: a manually curated database for piRNA associated diseases. Database (Oxford). 2019; 2019. PMC: 6606758. DOI: 10.1093/database/baz052. View

5.
Viswanathan S, Powers J, Einhorn W, Hoshida Y, Ng T, Toffanin S . Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet. 2009; 41(7):843-8. PMC: 2757943. DOI: 10.1038/ng.392. View